Michael A. Lyons

Bedaquiline and Pyrazinamide Treatment Responses Are Affected by Pulmonary Lesion Heterogeneity in <i>Mycobacterium tuberculosis</i> Infected C3HeB/FeJ Mice

Scott M. Irwin, Brendan Prideaux, Edward Lyon et al. · ACS Infectious Diseases · 2016 · 155 citations · Full text

Medicine, Infectious Diseases, Pharmacology +15

Computational Toxicology of Chloroform: Reverse Dosimetry Using Bayesian Inference, Markov Chain Monte Carlo Simulation, and Human Biomonitoring Data

Michael A. Lyons, Raymond S. H. Yang, Arthur N. Mayeno et al. · Environmental Health Perspectives · 2008 · 67 citations · Full text

Pharmacy, Biostatistics, Toxicology +17

A Physiologically Based Pharmacokinetic Model of Rifampin in Mice

Michael A. Lyons, Brad Reisfeld, Raymond S. H. Yang et al. · Antimicrobial Agents and Chemotherapy · 2013 · 45 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +16

Modeling and Simulation of Pretomanid Pharmacokinetics in Pulmonary Tuberculosis Patients

Michael A. Lyons · Antimicrobial Agents and Chemotherapy · 2018 · 32 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Digital Image Analysis of Heterogeneous Tuberculosis Pulmonary Pathology in Non-Clinical Animal Models using Deep Convolutional Neural Networks

Bryce Asay, Blake Blue Edwards, Jenna Andrews et al. · Scientific Reports · 2020 · 26 citations · Full text

Medicine, Pathobiology, Pathology +16